Earlier quoted context omitted.
How about an actually randomly sampled test, for starters?
It's the "for starters" that concerns me. A lot of us were always saying that official case counts are much too low, and antibody surveys were supposed to be the definitive proof that we were responsibly waiting for. Now they're starting to come out, and still nobody believes it. I worry it's a moving goalpost, and no evidence will ever be enough to make people start reconsidering their beliefs.
But the 21% study is seriously flawed because it didn't do a random sampling of the population. We need that at a minimum to know with any certainty what the actual exposure rate is. The figures that are coming back from studies using random samples in other places have been much lower.